JP2024513392A5 - - Google Patents

Info

Publication number
JP2024513392A5
JP2024513392A5 JP2023560497A JP2023560497A JP2024513392A5 JP 2024513392 A5 JP2024513392 A5 JP 2024513392A5 JP 2023560497 A JP2023560497 A JP 2023560497A JP 2023560497 A JP2023560497 A JP 2023560497A JP 2024513392 A5 JP2024513392 A5 JP 2024513392A5
Authority
JP
Japan
Prior art keywords
lys
cys
substituted
1peg2
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560497A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513392A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/022809 external-priority patent/WO2022212696A1/en
Publication of JP2024513392A publication Critical patent/JP2024513392A/ja
Publication of JP2024513392A5 publication Critical patent/JP2024513392A5/ja
Priority to JP2026038265A priority Critical patent/JP2026088199A/ja
Pending legal-status Critical Current

Links

JP2023560497A 2021-04-01 2022-03-31 コンジュゲートされたヘプシジン模倣物 Pending JP2024513392A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026038265A JP2026088199A (ja) 2021-04-01 2026-03-10 コンジュゲートされたヘプシジン模倣物

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163169538P 2021-04-01 2021-04-01
US202163169527P 2021-04-01 2021-04-01
US202163169533P 2021-04-01 2021-04-01
US63/169,538 2021-04-01
US63/169,527 2021-04-01
US63/169,533 2021-04-01
US202263325323P 2022-03-30 2022-03-30
US63/325,323 2022-03-30
PCT/US2022/022809 WO2022212696A1 (en) 2021-04-01 2022-03-31 Conjugated hepcidin mimetics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026038265A Division JP2026088199A (ja) 2021-04-01 2026-03-10 コンジュゲートされたヘプシジン模倣物

Publications (2)

Publication Number Publication Date
JP2024513392A JP2024513392A (ja) 2024-03-25
JP2024513392A5 true JP2024513392A5 (cg-RX-API-DMAC7.html) 2025-03-06

Family

ID=83456776

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023560497A Pending JP2024513392A (ja) 2021-04-01 2022-03-31 コンジュゲートされたヘプシジン模倣物
JP2026038265A Pending JP2026088199A (ja) 2021-04-01 2026-03-10 コンジュゲートされたヘプシジン模倣物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026038265A Pending JP2026088199A (ja) 2021-04-01 2026-03-10 コンジュゲートされたヘプシジン模倣物

Country Status (7)

Country Link
US (1) US20250277012A1 (cg-RX-API-DMAC7.html)
EP (1) EP4314017A4 (cg-RX-API-DMAC7.html)
JP (2) JP2024513392A (cg-RX-API-DMAC7.html)
AU (1) AU2022249095A1 (cg-RX-API-DMAC7.html)
CA (1) CA3213688A1 (cg-RX-API-DMAC7.html)
TW (1) TW202304951A (cg-RX-API-DMAC7.html)
WO (1) WO2022212696A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4091624A1 (en) 2013-03-15 2022-11-23 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
CA2949215C (en) 2014-05-16 2023-03-14 Protagonist Therapeutics, Inc. .alpha.4.beta.7 integrin thioether peptide antagonists
SG10201810154WA (en) 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
WO2018022937A1 (en) 2016-07-27 2018-02-01 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
WO2019157268A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
MX2022008740A (es) 2020-01-15 2022-09-23 Janssen Biotech Inc Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
SMT202500254T1 (it) 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie
AU2021383828A1 (en) 2020-11-20 2023-07-06 Janssen Pharmaceutica Nv Compositions of peptide inhibitors of interleukin-23 receptor
KR20240034224A (ko) 2021-07-14 2024-03-13 얀센 바이오테크 인코포레이티드 인터류킨-23 수용체의 지질화된 펩티드 억제제
US20250170216A1 (en) * 2022-02-02 2025-05-29 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
EP4472995A4 (en) * 2022-02-02 2025-11-19 Protagonist Therapeutics Inc Conjugated hepcidin mimetics

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002079235A2 (en) * 2001-03-30 2002-10-10 University Of Copenhagen Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
EP4091624A1 (en) * 2013-03-15 2022-11-23 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
AU2015279571A1 (en) * 2014-06-27 2017-02-02 Protagonist Therapeutics, Inc. Hepcidin and mini-hepcidin analogues and uses therof
CA3009834A1 (en) * 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
WO2018128828A1 (en) * 2016-12-23 2018-07-12 Bayer Healthcare Llc Novel hepcidin mimetics and uses thereof
WO2019157268A1 (en) * 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
US20220372099A1 (en) * 2019-09-03 2022-11-24 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
IL299530A (en) * 2020-07-28 2023-02-01 Protagonist Therapeutics Inc Psidine is a conjugated mimetic

Similar Documents

Publication Publication Date Title
JP2024513391A5 (cg-RX-API-DMAC7.html)
JP2023540679A5 (cg-RX-API-DMAC7.html)
JP2023536463A5 (cg-RX-API-DMAC7.html)
US12234300B2 (en) Conjugated hepcidin mimetics
US10278957B2 (en) Opioid agonist peptides and uses thereof
ES3058577T3 (en) Conjugated hepcidin mimetics for use in treating of polycythemia vera
CN105451755B (zh) 铁调素类似物和其用途
ES2890600T3 (es) Péptidos de tioéter antagonistas de integrina alfa4beta7
CA3189432A1 (en) Conjugated hepcidin mimetics
US20240293511A1 (en) Hepcidin mimetics for treatment of hereditary hemochromatosis
JP7849383B2 (ja) コンジュゲートされたヘプシジン模倣物
JP2012530145A5 (cg-RX-API-DMAC7.html)
WO2017117411A1 (en) Analogues of hepcidin mimetics with improved in vivo half lives
WO2022212696A1 (en) Conjugated hepcidin mimetics
JP2015533833A5 (cg-RX-API-DMAC7.html)
US20240226225A1 (en) Conjugated hepcidin mimetics
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
SK150196A3 (en) Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use
CN117480176A (zh) 用于治疗遗传性血色病的铁调素模拟物
EA053112B1 (ru) Конъюгированные миметики гепсидина
CN117730089A (zh) 结合型铁调素模拟物
JPS62111997A (ja) ポリペプチド
NZ751741B2 (en) Hepcidin analogues and uses therof